PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2023, PANACEA LIFE SCIENCES HOLDINGS, INC. reported revenue of $2.38M, up 46.6% from the prior year. The company ran a net loss, with a net margin of -336.1% and a gross margin of 47.0%. It held $17.98M in total assets against $26.27M in total liabilities.
Key ratios (FY2023)
47.0%
Gross margin
-232.5%
Operating margin
-336.1%
Net margin
+46.6%
Revenue growth (YoY)
| Metric (FY) | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.38M | $1.63M | $2.06M | — | — | — | — | — | — | — |
| Cost of Revenue | $1.26M | $1.23M | $1.52M | $7.02M | $1.94M | $0 | — | — | — | — |
| Gross Profit | $1.12M | $396.5K | $540.6K | $2.00M | -$1.70M | $0 | — | — | — | — |
| Operating Income | -$5.55M | -$5.65M | -$5.94M | -$5.26M | -$10.67M | -$2.44M | -$3.12M | -$1.60M | -$389.3K | -$420.3K |
| Net Income | -$8.02M | -$9.14M | -$4.78M | -$5.23M | -$10.02M | -$4.34M | -$3.86M | -$1.60M | -$358.0K | -$296.6K |
| EPS (Diluted) | $-0.48 | $-0.62 | $-0.28 | — | — | — | — | — | — | — |
| Total Assets | $17.98M | $19.49M | $23.78M | $31.36M | $8.02M | $14.3K | $172.7K | $2.13M | $84.9K | $84.8K |
| Total Liabilities | $26.27M | $21.63M | $16.68M | $24.65M | $4.13M | $3.44M | $2.39M | $625.0K | $178.2K | $39.0K |
| Shareholders' Equity | -$8.29M | -$2.14M | $7.10M | $6.71M | $11.94M | -$3.42M | -$2.22M | $1.50M | -$93.3K | $45.8K |
| Cash & Equivalents | $100.9K | $7.0K | $19.8K | $84.4K | $18.4K | $2.0K | $161.2K | $1.06M | $0 | $41.7K |
| Operating Cash Flow | -$1.52M | -$2.40M | -$3.92M | -$7.65M | -$5.75M | -$465.8K | -$1.23M | -$891.0K | -$640.0K | -$399.6K |
| Capital Expenditures | $65.3K | $243.8K | $162.9K | $3.20M | $541.2K | $0 | — | -$1.3K | $0 | $6.0K |
| Shares Outstanding | 17.65M | 14.97M | 14.07M | 16.92M | 43.82M | 6.23M | 4.38M | 34.07M | 515.3K | 15.14M |